Biohaven Ltd. announced scientific leadership transitions effective July 13, 2026, where Dr.. Bruce Car will retire as Chief Scientific Officer and transition to a part-time role as Chief Innovation Officer, resulting in a 50% salary reduction. Concurrently, David Pirman, Ph.D., has been promoted to Executive Vice President and Head of Discovery to lead the internal drug-discovery organization. Biohaven Ltd. operates in the biotechnology industry, focusing on the development of novel therapeutic solutions.
